Cardiac Medical Device Market - Size, Share, Industry Trends, and Forecasts (2023 - 2030)

By Product Type :

Based on the product type, the market is bifurcated into diagnostic & monitoring and therapeutic & surgical devices.

Trends in the Product Type:

• The revolution of personalized implants, prosthetics, and surgical instruments is driving the adoption of 3D printing in therapeutic & surgical devices, which in turn is boosting the cardiac medical device market trends.
• The proliferation of minimally invasive procedures is driving the diagnostic & monitoring segment, which in turn is boosting the cardiac medical device market trends.

Therapeutic & Surgical Devices accounted for the largest revenue share in the year 2024.

• The devices are primarily used for cardiac treatment to ensure efficient correction and regulation of an abnormal heart rhythm.
• Additionally, the development of advanced technologies is propelling the adoption of therapeutic & surgical devices, which in turn is boosting the cardiac medical device market share.
• Further, the increasing prevalence of cardiovascular diseases (CVDs) and the aging global population are driving the demand for therapeutic & surgical devices, which in turn is boosting the cardiac medical device market share.
• For instance, in May 2023, Shockwave Medical, Inc. launched Shockwave C2+ Coronary Intravascular Lithotripsy (IVL) Catheter designed for the treatment of calcified coronary artery disease.
• Thus, according to the cardiac medical device market analysis, the increasing prevalence of cardiovascular diseases (CVDs) and the aging global population are driving the market progress.

Diagnostic & Monitoring is anticipated to register the fastest CAGR during the forecast period.

• The prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer increases, creating a higher demand for diagnostic tools and monitoring systems.
• Additionally, the rising adoption of advanced imaging tools, robotics, and wearable technology for better diagnosis & monitoring boosts the cardiac medical device market size.
• Further, the growing adoption of remote patient monitoring systems and telehealth technologies is driving the need for diagnostic & monitoring devices, which in turn boosts the cardiac medical device market size.
• Therefore, as per the market analysis, the growing adoption of remote patient monitoring systems and telehealth technologies is anticipated to boost the market during the forecast period.

By Application:

Based on the application, the market is segmented into cardiac arrhythmia, coronary artery disease, heart failure, and others.

Trends in the Application:

• The trend towards the prevalence of AI-powered diagnostics tools to improve risk assessment and treatment planning for coronary artery disease (CAD) is driving the market progress.
• The trend towards rising adoption of left ventricular assist devices designed for refractory heart failure is propelling the adoption in heart failure applications.

Coronary Artery Disease accounted for the largest revenue share in the year 2024.

• Devices such as cardiac imaging equipment are crucial for early and accurate diagnosis of coronary artery disease (CAD).
• Additionally, advances in technology allow for remote monitoring of patients with CAD, improving access to care and potentially reducing the need for frequent hospital visits.
• Further, the key factor driving the market adoption is due to the prevalence of sedentary lifestyles, poor dietary habits, and obesity, which in turn are major contributors to the development of CAD.
• For instance, according to the U.S. Department of Health & Human Services, coronary heart disease killed approximately 382,820 people in 2020, which in turn is driving the market adoption.
• Thus, according to the cardiac medical device market analysis, the prevalence of sedentary lifestyles, poor dietary habits, and obesity is driving the market adoption.

Heart Failure is anticipated to register the fastest CAGR during the forecast period.

• The increasing prevalence of high low-density lipoprotein (LDL) cholesterol, high blood pressure, and diabetes, among others, is driving the market adoption for heart failure applications.
• Additionally, the increasing incidence of heart failure is driving the market adoption.
• Further, the advancements in both drug therapies and medical devices are boosting the market adoption for heart failure applications.
• Therefore, as per the market analysis, the increasing incidents of heart failure are anticipated to boost the market during the forecast period.

By Regional Analysis:

The regions covered are North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

North America is estimated to reach over USD 37.50 Billion by 2032 from a value of USD 22.79 Billion in 2024 and is projected to grow by USD 23.85 Billion in 2025. Out of this, U.S. accounted for the maximum revenue share of 70.75%. The North American region's high adoption rate of advanced devices and procedures like minimally invasive interventions offers lucrative growth prospects for the market. Additionally, the presence of a large number of hospitals equipped with innovative technology is driving the market's progress.

• For instance, in June 2025, GE HealthCare launched innovative molecular imaging solutions for cardiovascular disease. The advanced diagnostic technology plays a crucial role in cardiac care by providing detailed insights into biological processes beyond conventional imaging.

Asia Pacific region was valued at USD 16.36 Billion in 2024. Moreover, it is projected to grow by USD 17.15Billion in 2025 and reach over USD 27.44 Billion by 2032. The market progress is mainly driven by the growing demand for highly advanced cardiac devices. Furthermore, factors including the rising disposable incomes and government initiatives to improve healthcare access are projected to drive the market progress in the Asia Pacific region during the forecast period.

• For instance, in June 2025, Foldax launched Mitral Valve, approved by CDSCO, aiming to stabilize hemodynamics and achieve meaningful improvements in patient quality of life.

The regional analysis depicts that the shift towards minimally invasive procedures, remote patient monitoring, and others is driving the market in Europe. Additionally, the key factor driving the market is the rise in wearable and home-based monitoring devices, as well as the integration of IoT and AI in cardiac care is propelling the market adoption in the Middle East and African region. Further, the growing demand for advanced diagnostic and monitoring devices is paving the way for the progress of the market in the Latin American region.